CDT Equity Inc.

13F holders, Q2 2025 (June 30)
14holders
$2.74avg. 13F price*

At the end of Q2 2025, 14 institutions reported holding CDT Equity Inc. in their 13F filings. The largest holders were UBS Group AG ($36K), FMR LLC ($12K) and Tower Research Capital LLC (TRC) ($3K).

Company
CDT Equity Inc.
Filed as
CONDUIT PHARMACEUTICALS INC (Q2 2025)
CUSIP
20678X304
Latest filing quarter
Q3 2025

History

Number of 13F holders

051015 Q2 2025: 14Q2 2025Q3 2025: 9Q3 2025

Total Exit/New Position Q2 2025

InstitutionsTotal Value
New Positions15$56K
Exits0$0

Ownership 14 holders

UBS Group AG 0.00% New 13,219 $36K
FMR LLC 0.00% New 4,527 $12K
Tower Research Capital LLC (TRC) 0.00% New 982 $3K
Cwm, LLC 0.00% New 852 $2K
Bank of America Corp. 0.00% New 326 $900
Deutsche Bank AG 0.00% New 294 $811
Morgan Stanley 0.00% New 226 $624
BlackRock, Inc. 0.00% New 74 $204
SBI Securities Co., Ltd. 0.00% New 20 $55
EverSource Wealth Advisors, LLC 0.00% New 18 $50
BNP Paribas Financial Markets 0.00% New 15 $41
Wells Fargo & Company 0.00% New 10 $28
Sterling Capital Management LLC 0.00% New 10 $28
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 0.00% New 6 $17

"% of holder's portfolio" is CDT EQUITY INC's weight in each manager's 13F, not the share of CDT Equity Inc. the manager owns.